Our Senior Vice President of Process and Analytical Development, Jeff Allen, PhD, presented a scientific poster at BioProcess International US West in San Diego (March 9–11). Showcased how Pfenex Expression Technology® is advancing scalable, high-yield recombinant peptide production, offering a more sustainable alternative to traditional solid phase peptide synthesis (SPPS), with clinical validation through teriparatide.
